Stock SAGE SAGE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Sage Therapeutics, Inc.

Equities

SAGE

US78667J1088

Market Closed - Nasdaq
Other stock markets
 04:00:04 2024-07-12 pm EDT 		5-day change 1st Jan Change
11.76 USD +0.21% Intraday chart for Sage Therapeutics, Inc. +9.09% -45.73%
Jul. 12 JPMorgan Lowers Price Target on Sage Therapeutics to $18 From $23, Maintains Overweight Rating MT
Jul. 09 RBC Cuts Price Target on Sage Therapeutics to $12 From $15, Keeps Sector Perform Rating MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lantheus Holdings, Inc. Appoints Jamie Spaeth as Chief People Officer
CI
Sage Therapeutics, Inc. Announces Not Standing for Re-Election of Board of Directors
CI
Sage Therapeutics, Inc. Announces Not Standing for Re-Election of Board of Directors
CI
Sage Therapeutics, Inc. Announces the Retirement of Steven Paul from the Board
CI
Sage Therapeutics, Inc. Announces Changes to Board of Directors
CI
Sage Therapeutics to Lay Off 40% Staff Amid Efforts to Support Financial Position
MT
Sage Therapeutics, Inc. Announces Management Changes
CI
Sage Therapeutics, Inc Appoints Jessica J. Federer to the Board
CI
Insider Sell: Sage Therapeutics
MT
Insider Buy: Sage Therapeutics
MT
Sage Therapeutics, Inc. Announces Resignation of Jeffrey M. Jonas as Chief Innovation Officer
CI
Sage Therapeutics Appoints Laura M. Gault as Chief Medical Officer
CI
Insider Buy: Sage Therapeutics
MT
Sage Therapeutics Appoints Mark Pollack as Senior Vice President, Medical Affairs
CI
Sage Therapeutics : Names Chris Benecchi as Chief Commercial Officer
MT
Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
CI
Insider Trends: Sage Therapeutics Insider 90-Day Buying Trend Continued with Purchase
MT
Insider Trends: Insider Purchase Continues Sage Therapeutics Positive Trend
MT
Insider Trends: Insider Purchase of Sage Therapeutics Stock Extends 90-Day Positive Trend
MT
Sage Therapeutics, Inc. Announces Departure of Mike Cloonan as Chief Operating Officer, Effective May 3, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SAGE Stock
  4. News Sage Therapeutics, Inc.
  5. Insiders